Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 1;35(13):2276-2282.
doi: 10.1093/bioinformatics/bty949.

Application of machine learning techniques to tuberculosis drug resistance analysis

Affiliations

Application of machine learning techniques to tuberculosis drug resistance analysis

Samaneh Kouchaki et al. Bioinformatics. .

Abstract

Motivation: Timely identification of Mycobacterium tuberculosis (MTB) resistance to existing drugs is vital to decrease mortality and prevent the amplification of existing antibiotic resistance. Machine learning methods have been widely applied for timely predicting resistance of MTB given a specific drug and identifying resistance markers. However, they have been not validated on a large cohort of MTB samples from multi-centers across the world in terms of resistance prediction and resistance marker identification. Several machine learning classifiers and linear dimension reduction techniques were developed and compared for a cohort of 13 402 isolates collected from 16 countries across 6 continents and tested 11 drugs.

Results: Compared to conventional molecular diagnostic test, area under curve of the best machine learning classifier increased for all drugs especially by 23.11%, 15.22% and 10.14% for pyrazinamide, ciprofloxacin and ofloxacin, respectively (P < 0.01). Logistic regression and gradient tree boosting found to perform better than other techniques. Moreover, logistic regression/gradient tree boosting with a sparse principal component analysis/non-negative matrix factorization step compared with the classifier alone enhanced the best performance in terms of F1-score by 12.54%, 4.61%, 7.45% and 9.58% for amikacin, moxifloxacin, ofloxacin and capreomycin, respectively, as well increasing area under curve for amikacin and capreomycin. Results provided a comprehensive comparison of various techniques and confirmed the application of machine learning for better prediction of the large diverse tuberculosis data. Furthermore, mutation ranking showed the possibility of finding new resistance/susceptible markers.

Availability and implementation: The source code can be found at http://www.robots.ox.ac.uk/ davidc/code.php.

Supplementary information: Supplementary data are available at Bioinformatics online.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Classification performance (AUC%) considering six machine learning classifiers (LR with L1 and L2 regularization terms, SVM with Linear and RBF kernels, RF, Adaboost, PM and GBT) across 11 anti-TB drugs and F1 feature space
Fig. 2.
Fig. 2.
Classification performance (AUC%) considering six machine learning classifiers across 11 anti-TB drugs with (a) SNMF-F1 and (b) SPCA-F1

References

    1. Benetos E., et al. (2006) Applying supervised classifiers based on non-negative matrix factorization to musical instrument classification. In: 2006 IEEE International Conference on Multimedia and Expo, IEEE, Toronto, Ontario, Canada, pp. 2105–2108.
    1. Coll F., et al. (2015) Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med., 7, 1–10. - PMC - PubMed
    1. CRyPTIC Consortium and the 100 000 Genomes Project. (2018) Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing. N. Engl. J. Med, 379, 1403–1415. - PMC - PubMed
    1. Eckart C., Young G. (1936) The approximation of one matrix by another of lower rank. Psychometrika, 1, 211–218.
    1. Ehrentraut C., et al. (2016) Detecting hospital-acquired infections: a document classification approach using support vector machines and gradient tree boosting. Health Inform. J., 24, 24–42. - PMC - PubMed

Publication types

Substances